Furthermore, NVP-LDE225 diminished the expression of MRP1, a drug efflux pump, and augmented the sensitivity of cells to chemotherapeutic drugs such as paclitaxel, effectively reversing the drug resistance of tumor cells. Here, MDM4 is linked to neoplasm.